Search results for "Kidney disease"
Higher baclofen dosage associated with encephalopathy in older patients with CKD
A retrospective Canadian study compared 30-day risk for encephalopathy in older patients with chronic kidney disease (CKD) who were newly prescribed at least 20 mg of baclofen per day versus a lower dose, as well as in baclofen users versus nonusers.
https://immattersacp.org/weekly/archives/2019/11/12/4.htm
12 Nov 2019
Non-vitamin K oral anticoagulants appear superior to vitamin K antagonists in early-stage CKD
An accompanying editorial said that the current review supports a superior benefit profile of non-vitamin K oral anticoagulants (NOACs) in patients with atrial fibrillation and early-stage chronic kidney disease (CKD).
https://immattersacp.org/weekly/archives/2019/07/16/2.htm
16 Jul 2019
Racial, economic disparities found in use of SGLT-2 inhibitors
Although use of sodium-glucose cotransporter-2 (SGLT-2) inhibitors rose overall between 2015 and 2019, patients who were Black, Asian, female, or with lower household income had lower rates of prescriptions for the drug class than others with type 2 diabetes.
https://immattersacp.org/weekly/archives/2021/04/20/2.htm
20 Apr 2021
MKSAP Quiz: Follow-up for primary membranous glomerulopathy
A 38-year-old woman is evaluated during a follow-up visit for primary membranous glomerulopathy diagnosed by kidney biopsy 4 months ago. She was found to be positive for anti–phospholipase A2 receptor (PLA2R) antibodies. Vital signs are normal and there is pitting lower extremity edema to the mid shins bilaterally. What complication is she at risk for developing?
https://immattersacp.org/weekly/archives/2019/11/05/3.htm
5 Nov 2019
MKSAP Quiz: 5-year history of recurrent gout
A 53-year-old man is evaluated for a 5-year history of recurrent gout attacks involving the base of the great toes, mid feet, and ankles. Episodes are becoming more frequent and severe. History is also significant for hypertension and stage 3 chronic kidney disease. Following a physical exam and lab studies, what is the most appropriate next step in management?
https://immattersacp.org/weekly/archives/2018/12/11/3.htm
11 Dec 2018
Intensive blood pressure lowering may not induce true kidney disease
The findings can help improve understanding of the significance of creatinine elevations observed during hypertension therapy.
https://immattersacp.org/weekly/archives/2018/10/23/1.htm
23 Oct 2018
MKSAP Quiz: Ulcerating, painful lesion
A 72-year-old man is evaluated for an ulcerating, painful lesion on his left calf that began as a patch of red skin 2 to 3 weeks ago. He has dialysis-dependent end-stage kidney disease, atrial fibrillation, and hypertension. Following a physical exam and other tests, what is the most likely diagnosis?
https://immattersacp.org/archives/2022/02/mksap-quiz-ulcerating-painful-lesion.htm
1 Feb 2022
ACP's Performance Measurement Committee review has led to changes in quality measures
Of 30 quality measures that the committee found invalid in an assessment of the 2017 Merit-Based Incentive Payment System (MIPS), 12 are either already removed or scheduled for removal.
https://immattersacp.org/weekly/archives/2020/10/27/5.htm
27 Oct 2020
Best practices for HCV care include less invasive testing for many patients, says ACP
The College's new advice on treating hepatitis C virus (HCV) identifies patients who can be safely treated in primary care with laboratory monitoring limited to the beginning and end of treatment and no invasive testing.
https://immattersacp.org/weekly/archives/2020/10/06/4.htm
6 Oct 2020
Kidney failure, CV events lower with canagliflozin than placebo, industry study finds
The trial was stopped early after an interim safety analysis found significantly better renal and cardiovascular outcomes among type 2 diabetes patients randomized to canagliflozin than those assigned to placebo.
https://immattersacp.org/weekly/archives/2019/04/23/2.htm
23 Apr 2019